Development and introduction of recombinant factor VIII--a clinician's experience.
about
Helical organization of blood coagulation factor VIII on lipid nanotubes.Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) Congress: changing the policy landscape: haemophilia patient involvement in healthcare decision-making.Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics.
P2860
Development and introduction of recombinant factor VIII--a clinician's experience.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Development and introduction of recombinant factor VIII--a clinician's experience.
@en
type
label
Development and introduction of recombinant factor VIII--a clinician's experience.
@en
prefLabel
Development and introduction of recombinant factor VIII--a clinician's experience.
@en
P2860
P1433
P1476
Development and introduction of recombinant factor VIII--a clinician's experience.
@en
P2093
J M Lusher
P2860
P304
P356
10.1111/J.1365-2516.2012.02804.X
P577
2012-04-19T00:00:00Z